Larvol Delta - Athos-Therapeutics-Receives-Regulatory-Approval-to-Initiate-Phase-I-Clinical-Trial-of-ATH063

ATH-63 - Athos Therap

https://www.prnewswire.com/news-releases/athos-therapeutics-erhalt-behordliche-zulassung-fur-den-beginn-der-klinischen-phase-i-studie-mit-ath-063-301785465.html

Mar 30, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next